GlassScriptPhysician profile
Sara Kubick
NPI 1396468096
$9,389.41
in general payments reported to CMS, 2019-2025
22 companies · $4,265 in 2025
The $4,265 reported for 2025 was more than what 92% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $233 · 2023: $2,448 · 2024: $2,443 · 2025: $4,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,714 · Travel and Lodging: $4,125 · Education: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,713.64 |
| Travel and Lodging | $4,125.32 |
| Education | $316.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,792.45 | 2022-2025 | Inbone, Hoffmann, Prostep Mica |
| Medical Device Business Services, INC. | $2,444.68 | 2023-2025 | Motoband |
| Orthofix Medical, INC. | $949.67 | 2023 | Truelok, Truelok System |
| Integra Lifesciences Corporation | $861.21 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Trimed, INC. | $824.12 | 2025 | |
| Treace Medical Concepts, INC. | $339.23 | 2024-2025 | |
| Smith+Nephew, INC. | $226.51 | 2023-2025 | Grafix Pl, Stravix Pl, Stravix |
| Vertex Pharmaceuticals Incorporated | $193.80 | 2024-2025 | |
| Carbofix Orthopedics INC | $159.61 | 2023 | |
| Bone Support INC. | $136.61 | 2024 | Ceramentbone Void Filler, Cerament G |
| Fusion Orthopedics USA, LLC | $128.98 | 2025 | |
| Heron Therapeutics, INC. | $79.84 | 2023 | Zynrelef |
| Depuy Synthes Sales INC. | $45.63 | 2025 | Motoband |
| Kci USA, INC. | $45.09 | 2022-2023 | Prevena |
| Kerecis Limited | $31.51 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $21.76 | 2023 | Qutenza |
| Paratek Pharmaceuticals, INC. | $21.54 | 2024 | Nuzyra |
| Mdd US Operations, LLC | $18.04 | 2023 | Apokyn, Myobloc, Xadago |
| Solventum Corporation | $17.96 | 2024 | Activ.A.C. |
| Medwest Associates | $17.52 | 2023 | |
| Enduromed, LLC | $17.38 | 2023 | |
| Zimvie INC. | $16.27 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Kubick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.